Nearshore Protein: Abnormal Stock Price Fluctuations Expected Semi-Annual Loss of 26.5 - 29.5 Million Yuan in 2026

Jin'an Protein announced that the company's stock price deviated by over 30% in cumulative increases during the three consecutive trading days from August 12 to 14, which constitutes abnormal fluctuations. After self-examination, the company confirmed that its production and operations are normal, and there is no substantial information that should have been disclosed but was not. In 2025, revenue is projected to reach 146.4395 million yuan, an increase of 14.80% year-on-year, with a net loss of 77.7834 million yuan; in the first quarter of 2026, revenue is anticipated to be 37.2467 million yuan, an increase of 11.37% year-on-year, with a net loss of 10.6044 million yuan. For the first half of 2026, the estimated net loss is projected to be between 26.5 million and 29.5 million yuan, representing an increased loss compared to the same period last year. Additionally, as of the close on August 14, the company's price-to-sales ratio is higher than that of comparable companies in the same industry, reminding investors to pay attention to risks.